COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--Spectranetics Corporation (“Company”) (Nasdaq:SPNC) today reported the settlement of matters related to the federal investigation initiated by the Food & Drug Administration and U.S. Immigration and Customs Enforcement, which was previously announced in a press release dated September 4, 2008.
